Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United States

被引:21
作者
Haley, Connie A. [1 ,2 ]
Macias, Patricia [4 ]
Jasuja, Supriya [4 ]
Jones, Betsy A. [5 ]
Rowlinson, Marie-Claire [5 ]
Jaimon, Roshni [4 ]
Onderko, Pennelyn [4 ]
Darnall, Elaine [6 ]
Gomez, Maria E. [3 ]
Peloquin, Charles [7 ]
Ashkin, David [3 ,5 ]
Goswami, Neela D. [8 ]
机构
[1] Univ Florida, Southeast Natl TB Ctr, Gainesville, FL USA
[2] Univ Florida, Dept Med, Div Infect Dis & Global Med, Gainesville, FL USA
[3] Univ Florida, Gainesville, FL USA
[4] Cook Cty Dept Publ Hlth, Chicago, IL USA
[5] Florida Dept Hlth, Jacksonville, FL USA
[6] Illinois Dept Publ Hlth, Springfield, IL 62761 USA
[7] Univ Florida, Coll Pharm, Gainesville, FL USA
[8] Ctr Dis Control & Prevent, Atlanta, GA USA
基金
英国科研创新办公室;
关键词
D O I
10.3201/eid2701.203766
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The US Food and Drug Administration approved a 6-month regimen of pretomanid, bedaquiline, and linezolid for extensively drug-resistant or multidrug-intolerant tuberculosis after a trial in South Africa demonstrated 90% effectiveness 6 months posttreatment. We report on a patient who completed the regimen using a lower linezolid dose.
引用
收藏
页码:332 / 334
页数:3
相关论文
共 10 条
[1]   Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy [J].
Brown, Ashley N. ;
Drusano, George L. ;
Adams, Jonathan R. ;
Rodriquez, Jaime L. ;
Jambunathan, Kalyani ;
Baluya, Dodge L. ;
Brown, David L. ;
Kwara, Awewura ;
Mirsalis, Jon C. ;
Hafner, Richard ;
Louie, Arnold .
MBIO, 2015, 6 (06)
[2]   Treatment of Highly Drug-Resistant Pulmonary Tuberculosis [J].
Conradie, Francesca ;
Diacon, Andreas H. ;
Ngubane, Nosipho ;
Howell, Pauline ;
Everitt, Daniel ;
Crook, Angela M. ;
Mendel, Carl M. ;
Egizi, Erica ;
Moreira, Joanna ;
Timm, Juliano ;
McHugh, Timothy D. ;
Wills, Genevieve H. ;
Bateson, Anna ;
Hunt, Robert ;
Van Niekerk, Christo ;
Li, Mengchun ;
Olugbosi, Morounfolu ;
Spigelman, Melvin .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (10) :893-902
[3]   WHO global progress report on tuberculosis elimination [J].
Harding, Emilia .
LANCET RESPIRATORY MEDICINE, 2020, 8 (01) :19-19
[4]   Dose optimization of moxifloxacin and linezolid against tuberculosis using mathematical modeling and simulation [J].
Heinrichs, M. Tobias ;
Drusano, George L. ;
Brown, David L. ;
Maynard, Michael S. ;
Sy, Sherwin K. B. ;
Rand, Kenneth H. ;
Peloquin, Charles A. ;
Louie, Arnold ;
Derendorf, Hartmut .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 53 (03) :275-283
[5]   Pretomanid: First Approval [J].
Keam, Susan J. .
DRUGS, 2019, 79 (16) :1797-1803
[6]   Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis [J].
Lee, Myungsun ;
Lee, Jongseok ;
Carroll, Matthew W. ;
Choi, Hongjo ;
Min, Seonyeong ;
Song, Taeksun ;
Via, Laura E. ;
Goldfeder, Lisa C. ;
Kang, Eunhwa ;
Jin, Boyoung ;
Park, Hyeeun ;
Kwak, Hyunkyung ;
Kim, Hyunchul ;
Jeon, Han-Seung ;
Jeong, Ina ;
Joh, Joon Sung ;
Chen, Ray Y. ;
Olivier, Kenneth N. ;
Shaw, Pamela A. ;
Follmann, Dean ;
Song, Sun Dae ;
Lee, Jong-Koo ;
Lee, Dukhyoung ;
Kim, Cheon Tae ;
Dartois, Veronique ;
Park, Seung-Kyu ;
Cho, Sang-Nae ;
Barry, Clifton E., III .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (16) :1508-1518
[7]   Treatment of Drug-Resistant Tuberculosis An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline [J].
Nahid, Payam ;
Mase, Sundari R. ;
Migliori, Giovanni Battista ;
Sotgiu, Giovanni ;
Bothamley, Graham H. ;
Brozek, Jan L. ;
Cattamanchi, Adithya ;
Cegielski, J. Peter ;
Chen, Lisa ;
Daley, Charles L. ;
Dalton, Tracy L. ;
Duarte, Raquel ;
Fregonese, Federica ;
Horsburgh, C. Robert, Jr. ;
Khan, Faiz Ahmad ;
Kheir, Fayez ;
Lan, Zhiyi ;
Lardizabal, Alfred ;
Lauzardo, Michael ;
Mangan, Joan M. ;
Marks, Suzanne M. ;
McKenna, Lindsay ;
Menzies, Dick ;
Mitnick, Carole D. ;
Nilsen, Diana M. ;
Parvez, Farah ;
Peloquin, Charles A. ;
Raftery, Ann ;
Schaaf, H. Simon ;
Shah, Neha S. ;
Starke, Jeffrey R. ;
Wilson, John W. ;
Wortham, Jonathan M. ;
Chorba, Terence ;
Seaworth, Barbara .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 200 (10) :E93-E142
[8]   The Role of Therapeutic Drug Monitoring in Mycobacterial Infections [J].
Peloquin, Charles .
MICROBIOLOGY SPECTRUM, 2017, 5 (01)
[9]   Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis [J].
Song, Taeksun ;
Lee, Myungsun ;
Jeon, Han-Seung ;
Park, Yumi ;
Dodd, Lori E. ;
Dartois, Veronique ;
Follman, Dean ;
Wang, Jing ;
Cai, Ying ;
Goldfeder, Lisa C. ;
Olivier, Kenneth N. ;
Xie, Yingda ;
Via, Laura E. ;
Cho, Sang Nae ;
Barry, Clifton E., III ;
Chen, Ray Y. .
EBIOMEDICINE, 2015, 2 (11) :1627-1633
[10]  
Xu J, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00239-17, 10.1128/aac.00239-17]